That's the difference in the standing of Scarlett v/s West among investors!! Scarlett is no body, his reputation is even worse than Paul Wotton of Ocata!!
People are not selling!! Traders/shorts and hedgies playing games to make easy money!! These are the vermin that have infected securities markets and are there to stay!! get a feeling of their presence through lies and distortions in posts on this board!! could you have imagined this before Reagan's time? Computers and banks given the freedom to trade securities are the culprit. Monkeys, in hords, just hopping in and out!!!
You are right; it's not IMET, it's Scarlett and the board that investors don't seem to trust!! But, if the product's power is overwhelming in light of support from Mayo and Janssen, Scarlett and the stuffless board will be overridden!
That's the difference between West and Scarlett, a real-gem seeker v/s a shark searcher!! No wonder, Tefferi /Mayo and Janssen has done and will do what this bozo could not do!! Look at the SP of AST v/s Geron, former not have a single product even in Ph 2 v/s the latter
having a CR/PR getting BT product in Ph 2 and yet AST has become more of investors' darling than GERN!! Of course, it's the WS impression about West v/s Scarlett!!!
Huh may split from Scarlett and their relationship may have already soured since Scarlett had one of his persons from the old company brought into the board and the other one in the top management. Huh may cooperate and side with Janssen to beat Scarlett, along with other board members who themselves may have been fed up with Scarlett's arrogance.
It will be the board's decision and required approval; he can not act in isolation. Yes, he can influence if he gets the majority with him; but, he has only one board member he can count on to side with him. - the one he brought from the company he worked in the past.
Greg, if Geron owns the patent, it's more a reason for Janssen to acquire Geron, unless the Geron management is too greedy or in the fold of another large pharma to let that happen without resistance. However, I find that to be unlikely since the entire development work is transferred to Janssen; i.e., the Patent '615 must go hand-in-hand with that from the business-advantage point of view. I think something must be cooking up in this respect and. hence, the silence. Any leaked information w.r.t. this and a large pharma with completing drug plan can create road blocks. I think the best strategy is to keep holding Geron shares since the holders will be the beneficiary and since there is no other commercial-paper financing deal, like preferred shares. The common-share holders are the only beneficiaries, except the management guys who have options.
Development of Patent '615 must go hand-in-hand with that of IMET because the IMET patent may expire too soon to make decent profit!! Janssen guys are not dumb to see that and may already have that in their mind. They need to get hold of the patent and Gryaznov! Other large pharmas will be scared of future of their competiing products and, if this is delayed until they find that out, they will start a bidding war. Therefore, Janssen must make a move fast and suddenly.
Perhaps, Janssen may buyout Geron first and then AuraSense to grab Patent '615 to annex it to the further development of IMET!! the WS crooksshorts and monkey traders will never comprehend this and will be left in a puzzle and shock!! I will love that, if so!!
You never know! But, looking at what happened in case of Okarma who joined Asteria and took charge of all stem cell assets bought from Geron, this could be such a deal!!
AuraSense and brings Dr. Gryaznov back to Geron, who also owns Patent '615, using the JNJ money, and appoints him as the Chief Scientific Officer. I am sure, after that, a lot of large Pharmas beside JNJ will start looking to buy out Geron. Can Geron shareholders expect such a golden future for their investment? God only would know!! I will withdraw all my criticism of Scarlett and co. If they do this!!
Every year this happens, generally in September. This year, the China syndrome brought it earlier!! WS crooks just need an excuse to drag down the market. Too many computer-savvy guys looking for bonuses occupying banks' portfolios of funds and the entire financial district of Manhattan full of these people. Once these dogs have enough, suddenly, the market will bounce back and the cycle will resume. It is no longer securities market, it's a gambling casino and it will stay this way until govt. and legislators become wise and slash a heavy tax rate, like 60-80 percent, on short-term gains. That won't happen!!
If you have held on margin, it's a mistake because it is risky while Scarlett is in control. He is neither a Gates or a Jobbs, nor a Buffett!!
Manipulators, monkeys and the MM, taking advantage of no news and the China syndrome. Those who hold, must stay in, take a vacation, and just ignore the price drop. The WS crooks who have faked their sell rating will revert and change once those crooks have enough in their folios and ready to take profit. The bozos at Geron do not know how to deal with WS crooks OR are simply cooperating with them. They are all after stripping others to make their living. How you want to deal with all these croks is your choice. I have decided to ignore and stay assured of IMET success and confidence in Janssen and Tefferi. I have not much faith in anything else!!
That also will be what Warren Buffett would have advised if he was in Ocata. I think the company has intellectual wealth far more than what the SP suggests. It is just the traders and hedge funds playing seek and hide with the MM holding the strings. The company completed the last offering @ $5.5 based on Wotton's statement during the last CC which was a smart move; but, the WS crooks are brainwashing traders with lack of news on the Ph 2 scare! So, the monkeys are scared and those with margin are forced by the MM to dump. Also, when the other stocks doing well, the hedgies shift to what is hot, forcing monkeys to get dragged. I see a decent rise after this scare. And, those crooks will pocket hefty gains.